People with HIV aged 75 and older receiving good HIV care but many at risk of frailty

People with HIV aged 75 years and older are receiving “almost perfectly managed” care, but are more likely to experience age-related health conditions, according to French research published in Médecine et maladies infectieuses.

Read More

Switching from TDF to TAF associated with improvements in bone mineral density in people over 60

Switching tenofovir formulation was associated with increases in bone mineral density among older people with HIV, an international team of investigators report in The Lancet HIV. The study involved people with HIV over the age of 60 who had an undetectable viral load while taking an antiretroviral combination containing tenofovir disoproxil fumarate (TDF). Two-thirds were randomised to change to a fixed-dose combination containing the newer tenofovir alafenamide (TAF).

Read More